Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

IXICO chosen to provide services for second Alzheimer’s clinical trial in the span of one week

IXICO chosen to provide services for second Alzheimer’s clinical trial in the span of one week

IXICO PLC (LON:IXI) Chief Commercial Officer Lammert Albers tells Proactive the neuro-imaging specialist has been chosen to support an Alzheimer’s clinical trial; its second contract in this field in the space of just over a week.

Albers says what's more, the AD/PD 2021, Alzheimer's & Parkinson's Diseases Conference is being held this week, where many scientists from pharma companies are presenting on their own clinical assets on development.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK